Pretilachlor
Based on 1 Customer Validation
Pretilachlor is a chloroacetamide herbicide with biological activities including endocrine disruption, oxidative stress induction, apoptosis induction, and immunotoxicity. Pretilachlor exerts its effects by interfering with hormone metabolism, inducing oxidative stress, activating apoptotic pathways, and inhibiting immune functions. Pretilachlor upregulates the transcription of P53, Mdm2, and Bbc3, and increases the activities of Caspase3 and Caspase9; it upregulates the transcription of genes in the HPG/HPT axis and the activity of aromatase; it induces oxidative stress, elevates ROS levels, and upregulates CAT, SOD, and GPX. Pretilachlor downregulates the transcription of CXCL-C1C, IL-1β, and IL-8. Pretilachlor disrupts the normal physiological processes and embryonic development of fish, exhibiting significant toxicity. Pretilachlor can be used in studies related to weeding, environmental pollution, and behavioral toxicity in fish.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.25%
- CAS. Nr.: 51218-49-6
- Formel: C17H26ClNO2
- Molecular Weight:311.85
-
Speicherung:
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Alle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Caspase 3 |
Caspase 9 |
Aromatase |
IL-8 |
IL-1β |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:AB strain (embryos from adult females with average weight 0.93 g, males with average weight 0.65 g)[1]
-
Dosage:50 μg/L, 100 μg/L, 200 μg/L
-
Administration:aqueous exposure; continuous; 96 hours
-
Result:Upregulated VTG1 mRNA by 3.45-fold (50 μg/L), 2.74-fold (100 μg/L) and 2.43-fold (200 μg/L).
Upregulated CYP19a mRNA by 4.29-fold (50 μg/L); upregulated CYP19b mRNA by 3.29-fold (50 μg/L) and raised its level at 200 μg/L.
Elevated ERα mRNA at 200 μg/L; suppressed ERβ1 mRNA at 100 μg/L and 200 μg/L.
Raised TRα mRNA at 50 μg/L and 200 μg/L; upregulated Dio2 mRNA by 1.5-fold (50 μg/L).
Boosted VTG protein contents and aromatase activity at 50 μg/L and 100 μg/L.
Elevated T3 content at 100 μg/L; increased T4 content at 50 μg/L and 100 μg/L.
Suppressed CXCL-C1C mRNA across all tested concentrations.
Reduced IL-1β mRNA to 0.172-fold (50 μg/L), 0.350-fold (100 μg/L) and 0.400-fold (200 μg/L) in a dose-dependent manner.
Lowered IL-8 mRNA at 100 μg/L.
Upregulated CAT and Cu/Zn-SOD mRNA at 50 μg/L; upregulated GPX mRNA at 200 μg/L.
Increased CAT protein contents at 50 μg/L and 100 μg/L; enhanced CAT activity at 100 μg/L.
Raised SOD protein content at 50 μg/L; elevated GPX protein contents at 50 μg/L and 200 μg/L.
Elevated ROS levels at all tested concentrations.
Upregulated P53 mRNA at 50 μg/L and 200 μg/L; upregulated Mdm2 mRNA at 50 μg/L; upregulated Bbc3 mRNA by 2.08-fold (200 μg/L).
Enhanced Caspase3 activity at 100 μg/L and 200 μg/L; increased Caspase9 activity at 100 μg/L.
Chemical Information
-
CAS. Nr. 51218-49-6
-
Appearance Liquid (Density: 1.074±0.06 g/cm3)
-
Molecular Weight 311.85
-
Formel C17H26ClNO2
-
Color Colorless to light yellow
-
SMILES
O=C(N(C1=C(CC)C=CC=C1CC)CCOCCC)CCl
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Lösungsmittel & Löslichkeit
DMSO : 200 mg/mL (641.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Reinheit & Dokumentation
-
Data Sheet (275 KB)
-
SDS (420 KB)
- English - EN (420 KB)
- Français - FR (420 KB)
- Deutsch - DE (420 KB)
- Norwegian - NO (420 KB)
- Español - ES (420 KB)
- Swedish - SV (420 KB)
- Italian - IT (420 KB)
- Korean - KR (420 KB)
- Portuguese - PT (420 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.2067 mL | 16.0333 mL | 32.0667 mL | 80.1667 mL |
| 5 mM | 0.6413 mL | 3.2067 mL | 6.4133 mL | 16.0333 mL | |
| 10 mM | 0.3207 mL | 1.6033 mL | 3.2067 mL | 8.0167 mL | |
| 15 mM | 0.2138 mL | 1.0689 mL | 2.1378 mL | 5.3444 mL | |
| 20 mM | 0.1603 mL | 0.8017 mL | 1.6033 mL | 4.0083 mL | |
| 25 mM | 0.1283 mL | 0.6413 mL | 1.2827 mL | 3.2067 mL | |
| 30 mM | 0.1069 mL | 0.5344 mL | 1.0689 mL | 2.6722 mL | |
| 40 mM | 0.0802 mL | 0.4008 mL | 0.8017 mL | 2.0042 mL | |
| 50 mM | 0.0641 mL | 0.3207 mL | 0.6413 mL | 1.6033 mL | |
| 60 mM | 0.0534 mL | 0.2672 mL | 0.5344 mL | 1.3361 mL | |
| 80 mM | 0.0401 mL | 0.2004 mL | 0.4008 mL | 1.0021 mL | |
| 100 mM | 0.0321 mL | 0.1603 mL | 0.3207 mL | 0.8017 mL |